Table 1.

Baseline recipient and donor characteristicsa

Variable (% Missing Data)VA Users (n = 1646)Non-VA Users (n = 77,715)
African-American (n = 688)Non–African-American (n = 958)African-American (n = 19,323)Non–African-American (n = 58,392)
Recipient characteristics
    age (yr; mean ± SD; 0)48.5 ± 11.852.7 ± 10.744.7 ± 12.645.9 ± 13.1
    female gender (%; 0)544240
    BSA (m2; mean ± SD; 14)1.97 ± 0.181.97 ± 0.181.89 ± 0.211.84 ± 0.22
    employed (%; 18)38443229
    college educated (%; 49)49453947
    independent in activities of daily living (%; 15)64616669
    peak PRA (≥50%; 4)5496
    most recent PRA (%; 4)
        080787475
        <5018192222
        ≥501243
    vintage (months; median, 25th to 75th         quartile; 0)32.5, 17.7–49.821.4, 12.6-35.730.0, 16.3-48.718.4, 9.4-33.5
    PD at initiation of ESRD treatment (%; 0)12171624
    PD at the time of transplant (%; 0)10171524
    transplant era (% patients; 0)
        1991–199317191718
        1993–199522222121
        1995–199724232323
        1997–200037363938
    comorbidities (% with condition)
        treated COPD (38)12<1<1
        treated hypertension (38)84788175
        cerebrovascular disease (38)2222
        cardiovascular disease (38)1520812
        peripheral vascular disease (38)3735
        diabetes (34)28383035
Donor characteristics
    age (yr; mean ± SD; 6)36.1 ± 15.937.1 ± 15.735.2 ± 16.236.1 ± 15.9
    female gender (%; 1)39424345
    race (%; 3)
        African American295346
        Asian<11<12
        Caucasian70926491
        Other<11<11
    cause of death (% patients; 0)
        trauma37303328
        vascular (cerebrovascular and cardiovascular)37323529
        other26383242
    cold ischemia time (h; mean ± SD; 12)18.9 ± 10.617.2 ± 10.917.9 ± 11.215.7 ± 11.6
    HLA mismatch (%; 4)
        0514613
        13636
        29141115
        324262424
        426202620
        520142015
        6126107
    Donor type (% living; 0)12241929
  • a VA, Veterans Affairs; BSA, body surface area; PRA, panel reactive antibody; PD, peritoneal dialysis; COPD, chronic obstructive pulmonary disease.